Articles

PP45 Blood transfusion in Sickle Cell Disease. Retrospective study in ZNA Hospitals (Antwerp)

BJH - 2018, issue Abstract Book BHS, february 2018

T. Eyckmans MD, S. Mahieu , M.P. Emonds MD, PhD, E. Lazarova , P. Vandenberghe MD, PhD, P. Zachée MD, PhD

Read more

PP46 Blood transfusion management in the new era of immune therapy: experience from Dienst voor het Bloed, Rode Kruis-Vlaanderen

BJH - 2018, issue Abstract Book BHS, february 2018

E. Lazarova , M.P. Emonds MD, PhD, V. Pede , P. Gys , A. Muylaert , Prof P. Vandekerckhove PhD, V. Combernolle

Read more

Massive clotting in red cell concentrates during transfusion is caused by backflow of patient blood

BJH - volume 8, issue 5, september 2017

B. Van Aelst PhD, J. Coene MD, H.B. Feys PhD, M.P. Emonds MD, PhD, K. Van Poucke MD, J. Moerman MD, E. Verhoye MPharm , Prof V. Compernolle PhD

SUMMARY

We report three cases of massive ex vivo coagulation in a leukocyte depleted red cell concentrate during transfusion. Molecular blood typing indicated that patient blood was present in the filter housing of the infusion set and/or in the blood bag itself. Together with the history of events, this suggested that the observed clotting was caused by backflow of patient blood. Therefore, we recommend maintaining the blood bag above heart level during the entire transfusion procedure, until the infusion set is removed.

(BELG J HEMATOL 2017;8(5):195–7)

Read more